What is the equity of Adicet Bio this year?
Adicet Bio has equity of 170.18 M USD this year.
Adicet Bio Equity 2024
Adicet Bio Equity
170.18 M USD
Ticker
ACET
ISIN
US0070021086
WKN
A2QESQ
In 2024, Adicet Bio's equity was 170.18 M USD, a -41.78% increase from the 292.3 M USD equity in the previous year.
Adicet Bio Aktienanalyse
What does Adicet Bio do?
Adicet Bio Inc is a biopharmaceutical company specializing in the discovery and development of immune cell technologies for cancer therapy. The company was founded in 2015 by pharmaceutical expert Aya Jakobovits and has sister companies in Israel and the USA. The main mission of Adicet Bio is to provide better treatment and cure for cancer patients. The company utilizes its unique technologies and research findings to develop drugs that strengthen the body's immune system to fight cancer cells. Adicet Bio Inc focuses on studying the body's natural defense systems and utilizes innovative technologies such as CAR-T, gamma delta T cells, and other immune cell therapies. The company has a team of leading experts in immunology and cancer research. Adicet Bio offers its drugs and therapies in four different categories. The first category is CAR-T technology, a personalized immunotherapy where genetically modified T cells are produced in the laboratory to specifically destroy cancer cells. The second category is gamma delta T cells, which play an important role in fighting tumor cells as natural producers of cytokines. The third category at Adicet Bio Inc is its natural killer cells (NK cells), which play an important role in immune defense. And the fourth category offers a special type of antibodies (SAR-T) targeting bacterial and viral infections. Adicet Bio has multiple partnerships with leading companies and institutions worldwide, collaborating with universities, biotech companies, and cancer centers. The products and services of Adicet Bio have already been successfully tested in numerous clinical trials and have shown great efficacy. Adicet Bio is headquartered in Menlo Park, California, with a branch in Israel. The company employs around 60 employees worldwide, including many researchers and innovators who strive daily to provide better treatment for cancer patients. Adicet Bio Inc has already gained high regard in the industry and is seen by many experts, partners, and patients worldwide as a reputable and innovative company making a significant contribution to the development of cancer therapy. In a time where cancer treatments can be very burdensome for many patients, it is a special concern for Adicet Bio to develop and provide new therapies that improve the quality of life for cancer patients. The company is committed to its values such as innovation, integrity, excellence, and teamwork. Adicet Bio Inc is supported by leading investors worldwide and is an emerging biotechnology company that could potentially change the future of cancer treatment worldwide. Adicet Bio ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Adicet Bio's Equity
Adicet Bio's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Adicet Bio's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Adicet Bio's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Adicet Bio's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Adicet Bio’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Adicet Bio Stock
What was the equity of Adicet Bio compared to the previous year?
The equity of Adicet Bio has increased/decreased by -41.78% decreased compared to the previous year.
What impact does a high equity have on investors of Adicet Bio?
A high equity is advantageous for investors of Adicet Bio as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Adicet Bio?
A low equity can be a risk for investors of Adicet Bio, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Adicet Bio affect the company?
An increase in equity of Adicet Bio can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Adicet Bio affect the company?
A reduction in equity of Adicet Bio can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Adicet Bio?
Some factors that can affect the equity of Adicet Bio include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Adicet Bio so important for investors?
The equity of Adicet Bio is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Adicet Bio take to change the equity?
To change equity, Adicet Bio can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Adicet Bio pay?
Over the past 12 months, Adicet Bio paid a dividend of 0.08 USD . This corresponds to a dividend yield of about 5.81 %. For the coming 12 months, Adicet Bio is expected to pay a dividend of 0 USD.
What is the dividend yield of Adicet Bio?
The current dividend yield of Adicet Bio is 5.81 %.
When does Adicet Bio pay dividends?
Adicet Bio pays a quarterly dividend. This is distributed in the months of January, January, April, July.
How secure is the dividend of Adicet Bio?
Adicet Bio paid dividends every year for the past 0 years.
What is the dividend of Adicet Bio?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Adicet Bio located?
Adicet Bio is assigned to the 'Health' sector.
Wann musste ich die Aktien von Adicet Bio kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Adicet Bio from 6/22/2018 amounting to 0.01 USD, you needed to have the stock in your portfolio before the ex-date on 6/7/2018.
When did Adicet Bio pay the last dividend?
The last dividend was paid out on 6/22/2018.
What was the dividend of Adicet Bio in the year 2023?
In the year 2023, Adicet Bio distributed 0 USD as dividends.
In which currency does Adicet Bio pay out the dividend?
The dividends of Adicet Bio are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Adicet Bio
Our stock analysis for Adicet Bio Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Adicet Bio Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
